XML 23 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 6 - Share-based Compensation
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
6
.
Share-based Compensation
 
The Company has
one
active stock incentive plan for employees and directors
, the
2007
Stock Incentive Plan, which provides for awards of stock options to purchase shares of common stock, stock appreciation rights, restricted and unrestricted shares of common stock, restricted stock units (“RSUs”) and performance share awards (“PSAs”). In addition, the Company has
one
inactive stock option plan, the
1995
Stock Option Plan for Nonemployee Directors, under which previously granted options remain outstanding.
 
The Company recognizes
share-based compensation cost, based on grant date estimated fair value of the awards, over the period during which the employee or director is required to provide service in exchange for the award, and as forfeitures occur, the associated compensation cost recognized to date is reversed. The following table summarizes share-based compensation expense recorded (in thousands):
 
   
Three Months Ended September 30,
   
Nine Months Ended September 30,
 
   
2017
   
2016
   
2017
   
2016
 
                                 
Cost of sales
  $
70
    $
79
    $
221
    $
118
 
Selling, general and administrative expense
   
167
     
439
     
742
     
1,222
 
Loss from operations of discontinued operations
   
-
     
1
     
-
     
(8
)
Total
  $
237
    $
519
    $
963
    $
1,332
 
 
As of
September 
30,
2017,
unrecognized compensation expense related to the unvested portion of the Company’s RSUs was
$0.3
 million, which is expected to be recognized over a weighted average period of
0.3
 years.
 
 
Stock Option Awards
 
A summary of
option activity under the Company’s stock option plans as of
September 
30,
2017
and changes during the
nine
months then ended is presented below:
 
   
Options Outstanding
   
Weighted
Average
Exercise Price
   
Weighted
Average
Remaining Contractual
Life
   
Aggregate
Intrinsic Value
 
   
 
 
 
 
 
 
 
 
(in years)
   
(In thousands)
 
Balance, December 31, 2016
   
26,000
    $
24.97
     
 
     
 
 
Options granted
   
-
     
-
     
 
     
 
 
Options exercised
   
-
     
-
     
 
     
 
 
Options canceled
   
(2,000
)    
34.77
     
 
     
 
 
Balance, September 30, 2017
   
24,000
     
24.15
     
 
     
 
 
Exercisable, September 30, 2017
   
24,000
     
24.15
     
2.50
    $
-
 
 
Restricted Stock Units and Performance
Share
Awards
 
A summary of
activity under the Company’s RSUs and PSAs as of
September 
30,
2017
and changes during the
nine
months then ended is presented below:
 
   
Number of RSUs and PSAs
   
Weighted Average Grant Date Fair Value
 
Unvested RSUs and PSAs as of December 31, 2016
   
221,791
    $
17.36
 
RSUs and PSAs granted
   
-
     
-
 
Unvested RSUs and PSAs canceled
   
(46,988
)    
43.68
 
RSUs vested
   
(5,220
)    
36.00
 
Unvested RSUs as of September 30, 2017
   
169,583
     
9.50
 
 
RSUs and PSAs are measured at the estimated fair value on the date of grant. RSUs are service-based awards and vest according to vesting schedules, which range from immediate to ratably over a
three
-year period. PSAs are service-based awards
that vest over a
three
-year period and have a market-based payout condition. Vesting of the market-based PSAs is dependent upon the performance of the market price of the Company’s stock relative to a peer group of companies. In the
nine
months ended
September 
30,
2017,
the remaining PSAs were canceled because the market-based conditions were
not
achieved, and the actual number of common shares that were issued was determined by multiplying the PSAs by a payout percentage of
0%.
 
Stock Awards
 
During
the
nine
months ended
September 
30,
2017
and
2016,
stock awards of
14,944
and
27,640
shares, respectively, were granted to non-employee directors, which vested immediately upon issuance. The Company recorded compensation expense based on the fair market value per share of the awards on the grant date of
$14.72
and
$9.95
in
2017
and
2016,
respectively.